Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and PBMT for Knee Osteoarthritis
NCT06122116Terminated
- Sponsor
- MIRROR
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet rich gel in knee osteoarthritis (OA) (4 arms), sponsored by MIRROR. Primary endpoints: Kellgren Lawrence Classification System, Defense and Veterans Pain Rating Scale and 8 more. Started Oct 2023; status: terminated.
02
Drugs
autologous platelet rich gel
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06122116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06122116.